Investigating Global and Regional Trends of DALY due to Cardiovascular Diseases Using Latent Growth Model

Ahmad  BehnouieHeidari; Hossein  Fallahzadeh; Ramin Malboosbaf; Sara Jambarsang

doi:10.18502/tbj.v20i3.7466

Ahmad BehnouieHeidari M.Sc. of Biostatistics, Center for Healthcare Data Modeling, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Hossein Fallahzadeh Professor of Biostatistics, Center for Healthcare Data Modeling, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Ramin Malboosbaf Assistant Professor, Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical science, Tehran, Iran.
Sara Jambarsang Corresponding Author: Assistant Professor, Center for Healthcare Data Modeling, School of Public Health Shahid Sadoughi University of Medical Sciences.

DOI: https://doi.org/10.18502/tbj.v20i3.7466

Keywords: Cardiovascular Disease, Latent Growth Model, Global Burden of Disease, Disability

Abstract

Introduction: The global trend of cardiovascular diseases is increasing. This study was conducted to investigate the global and regional trends of DALY due to cardiovascular diseases during 1990-2017.

Methods: In this modeling study, the global burden rate of diseases, injuries, and risk factors by years of disability, years of life with disability, and years of life lost due to premature death related to cardiovascular diseases during 1990 to 2017 in 195 countries as the study population, which was extracted from the IHME site.

Results: The growth rate of DALY due to cardiovascular diseases in the high-income region (growth rate coefficient = 450.85) was higher than other regions and the highest mean DALY rate due to cardiovascular diseases was for Central and Eastern Europe and Central Asia (mean rate = 106767) compared to other regions. Overall, the growth rate of DALY due to cardiovascular diseases in the regions of Latin America and the Caribbean, South Asia and Southeast Asia, East Asia and Oceania was positive and the growth rate of DALY due to cardiovascular diseases was negative in Central Europe, Eastern Europe and Central Asia, high-income countries, North Africa and the Middle East and sub-Saharan Africa.